🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

TEVA GmbH — Licensed Medicines

37 medicines held by TEVA GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 37 products held by TEVA GmbH
MedicineActive substanceLicence holderStatus
AJOVY 225 mg Solution for injection
EU/1/19/1358/001-002
FREMANEZUMAB TEVA GmbH
Amlodipine Teva GmbH 10 mg tablets
PA22579/008/002
Amlodipine besilate TEVA GmbH Not marketed
Amlodipine Teva GmbH 5 mg tablets
PA22579/008/001
Amlodipine besilate TEVA GmbH Not marketed
Biopoin 1,000 IU/0.5 ml solution for injection in pre-filled syringe
EU/1/09/565/1-2
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 10,000 IU/1 ml solution for injection in pre-filled syringe
EU/1/09/565/11-16
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 2,000 IU/0.5 ml solution for injection in pre-filled syringe
EU/1/09/565/3-4
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 20,000 IU/1 ml solution for injection in pre-filled syringe
EU/1/09/565/17-22
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 3,000 IU/0.5 ml solution for injection in pre-filled syringe
EU/1/09/565/5-6
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 30,000 IU/1 ml solution for injection in pre-filled syringe
EU/1/09/565/23-28
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 4,000 IU/0.5 ml solution for injection in pre-filled syringe
EU/1/09/565/7-8
Xm01 drug substance epoetin theta TEVA GmbH
Biopoin 5,000 IU/0.5 ml solution for injection in pre-filled syringe
EU/1/09/565/9-10
Xm01 drug substance epoetin theta TEVA GmbH
Copaxone 20 mg/ml solution for injection in pre-filled syringe
PA22579/001/001
Glatiramer acetate TEVA GmbH Marketed
Copaxone 40mg/ml solution for injection in pre-filled syringe
PA22579/001/002
Glatiramer acetate TEVA GmbH Marketed
Dabigatran etexilate Teva 110 mg hard capsules
EU/1/23/1769/007-015
Dabigatran etexilate mesilate TEVA GmbH
Dabigatran etexilate Teva 150 mg hard capsules
EU/1/23/1769/016-023
Dabigatran etexilate mesilate TEVA GmbH
Dabigatran etexilate Teva 75 mg hard capsules
EU/1/23/1769/001-006
Dabigatran etexilate mesilate TEVA GmbH
Eltrombopag Teva 25 mg Film-coated Tablets
PA22579/003/001
Eltrombopag olamine TEVA GmbH Marketed
Eltrombopag Teva 50 mg Film-coated Tablets
PA22579/003/002
Eltrombopag olamine TEVA GmbH Not marketed
Enzalutamide Teva 40 mg film-coated tablets
PA22579/005/001
Enzalutamide TEVA GmbH Not marketed
Enzalutamide Teva 80 mg film-coated tablets
PA22579/005/002
Enzalutamide TEVA GmbH Not marketed
Nintedanib Teva 100 mg soft capsules
PA22579/007/001
Nintedanib esylate TEVA GmbH Marketed
Nintedanib Teva 150 mg soft capsules
PA22579/007/002
Nintedanib esylate TEVA GmbH Marketed
Nintedanib Teva GmbH 100 mg Soft Capsules
PA22579/010/001
Nintedanib esylate TEVA GmbH Not marketed
Nintedanib Teva GmbH 150 mg Soft Capsules
PA22579/010/002
Nintedanib esylate TEVA GmbH Not marketed
Pazopanib Teva 200 mg Film-coated Tablets
PA22579/006/001
Pazopanib hydrochloride TEVA GmbH Marketed
Pazopanib Teva 400 mg Film-coated Tablets
PA22579/006/002
Pazopanib hydrochloride TEVA GmbH Marketed
Pomalidomide Teva 1 mg Capsule, hard
EU/1/24/1868/001-012
Pomalidomide TEVA GmbH
Pomalidomide Teva 2 mg Capsule, hard
EU/1/24/1868/013-024
Pomalidomide TEVA GmbH
Pomalidomide Teva 3 mg Capsule, hard
EU/1/24/1868/025-036
Pomalidomide TEVA GmbH
Pomalidomide Teva 4 mg Capsule, hard
EU/1/24/1868/037-048
Pomalidomide TEVA GmbH
Ponlimsi 60 mg solution for injection in pre-filled syringe
EU/1/25/1986/001
Denosumab TEVA GmbH
Rivaroxaban Teva 10 mg film-coated tablets
PA22579/002/001
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Teva 15 mg film-coated tablets
PA22579/002/002
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Teva 20 mg film-coated tablets
PA22579/002/003
Rivaroxaban TEVA GmbH Marketed
Sacubitril/Valsartan Teva 24 mg/26 mg film-coated tablets
PA22579/004/001
Sacubitril sodium, Valsartan disodium TEVA GmbH Not marketed
Sacubitril/Valsartan Teva 49 mg/51 mg film-coated tablets
PA22579/004/002
Sacubitril sodium, Valsartan disodium TEVA GmbH Not marketed
Sacubitril/Valsartan Teva 97 mg/103 mg film-coated tablets
PA22579/004/003
Sacubitril sodium, Valsartan disodium TEVA GmbH Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.